登录

Radialogica和Scientific RT宣布在Sacro Cuore-Don Calabria癌症护理中心成功进行基于SciMoCa™Monte Carlo的Elekta Unity MR-Linac实时质量保证的临床前验证

Radialogica and Scientific RT Announce Successful Pre-Clinical Validation of SciMoCa™ Monte Carlo-Based Real-Time Quality Assurance for the Elekta Unity MR-Linac at Sacro Cuore-Don Calabria Cancer Care Center

CISION | 2024-05-03 | 翻译由动脉网AI生成,点击反馈

可切换为仅中文


ST. LOUIS, Mo., May 2, 2024 /PRNewswire/ -- Radialogica LLC and Scientific RT GmbH announced a pre-clinical version of SciMoCa™ for the Elekta Unity MR-Linac has been successfully validated at IRCCS Sacro Cuore-Don Calabria Cancer Care Center in regard to accuracy and integration within the demanding real-time adaptive workflow.

密苏里州圣路易斯,2024年5月2日/PRNewswire/--Radialogica LLC和Scientific RT GmbH宣布了用于Elekta Unity的SciMoCa™临床前版本。MR Linac已在IRCCS Sacro Cuore Don Calabria癌症护理中心成功验证了其在要求严格的实时自适应工作流程中的准确性和集成性。

Naturally, Monte Carlo dose computation is essential for irradiation in a magnetic field but there are challenges in achieving calculation times that fit within the time constraints of online treatment adaptation workflow..

自然,蒙特卡罗剂量计算对于磁场中的辐射至关重要,但在实现符合在线治疗适应工作流程时间限制的计算时间方面存在挑战。。

'The results of SciMoCa have been very impressive from the start, both in terms of accuracy and performance,' said Dr. Ruggero Ruggieri, MSc, Head of Medical Physics department at IRCCS Sacro Cuore-Don Calabria Cancer Care Center. 'We are expecting that the clinical version will be a huge advance in our quality assurance of treatment adaptation.'.

IRCCS Sacro Cuore Don Calabria癌症护理中心医学物理系主任、理学硕士Ruggero Ruggieri博士说:“SciMoCa从一开始就取得了非常令人印象深刻的结果,无论是在准确性还是性能方面。”我们期望临床版本将是我们治疗适应质量保证的巨大进步。”。

'The implementation of Unity support in our Monte Carlo-based secondary dose calculation has been an exciting project that built on our collective experience of 25 years of Monte Carlo development. I think the final result is a significant step forward not only for patient care but also in terms of its scientific novelty.

“在我们基于蒙特卡罗的二次剂量计算中实施统一支持是一个令人兴奋的项目,它建立在我们25年蒙特卡罗开发的集体经验基础上。我认为最终结果不仅对患者护理,而且就其科学新颖性而言,都是向前迈出的重要一步。

The collaboration with Sacro Cuore-Don Calabria was a tremendous help for us, for which we are hugely grateful,' said Dr. Markus Alber, Chief Executive Officer of Scientific RT..

Scientific RT首席执行官马库斯·阿尔伯(Markus Alber)博士说,与萨克罗·库雷·堂·卡拉布里亚(Sacro Cuore Don Calabria)的合作对我们来说是巨大的帮助,对此我们深表感谢。。

By adding support for the Unity MR-Linac SciMoCa strengthens its already broad support for Elekta treatment machines ranging from legacy devices to the most modern Linacs, from full-size MLCs to stereotactic collimators, and offering both state-of-the-art custom beam models as well as generic beam models compatible with Elekta's Accelerated-Go-Live offering.

通过增加对Unity的支持,Linac SciMoCa先生加强了对Elekta治疗机的广泛支持,从传统设备到最现代的直线加速器,从全尺寸MLC到立体定向准直器,并提供最先进的定制光束模型以及与Elekta加速上线产品兼容的通用光束模型。

With Unity support SciMoCa demonstrates its real-time capability for Monte Carlo-based dose calculations including logfile-based computations..

在Unity支持下,SciMoCa展示了其基于蒙特卡罗的剂量计算(包括基于日志文件的计算)的实时能力。。

Radialogica, a privately held company based in St. Louis, is a healthcare analytics company focused on radiation oncology for cancer patients. They provide software tools and analytics services to providers, payers and clinical trials sponsors with the goal of enhancing quality of care, improving patient outcomes, and reducing the physical and financial burden of cancer survivorship..

Radialogica是一家总部位于圣路易斯的私营公司,是一家专注于癌症患者放射肿瘤学的医疗保健分析公司。他们为提供者、付款人和临床试验赞助商提供软件工具和分析服务,旨在提高护理质量,改善患者预后,减轻癌症幸存者的身体和经济负担。。

Scientific RT, a privately held company based in Munich, is a scientific consulting and software development company specialized in medical physics. It has worked with the majority of global players in radiotherapy to provide tailored leading-edge software solutions and consulting for dose computation and dose optimization and maintains strong international links to academia..

Scientific RT是一家总部位于慕尼黑的私营公司,是一家专门从事医学物理学的科学咨询和软件开发公司。它与放射治疗领域的大多数全球参与者合作,为剂量计算和剂量优化提供量身定制的前沿软件解决方案和咨询,并与学术界保持密切的国际联系。。

CONTACT: Andrew Cowenandy@radialogica.com800-515-9132 ext. 101

联系人:AndrewCowenandy@radialogica.com800-515-9132分机101

SOURCE Radialogica LLC

SOURCE Radialogica有限责任公司

推荐阅读

华西医院:MRI引导放疗系统临床上线

器械之家 2024-04-27 19:48

GE医疗将与Elekta医科达进一步深化合作关系,在放射肿瘤学软件领域开展更多协作

思宇MedTech 2024-04-23 00:01

GE医疗与医科达合作,帮助加强放射治疗并改善患者预后

businesswire 2024-04-22 17:07

CISION

5258篇

最近内容 查看更多

Mallinckrodt在2024消化道疾病周®(DDW)上介绍了注射用TERLIVAZ®(特利加压素)治疗肝肾综合征(HRS)患者的数据

2 小时前

洛杉矶护理和加州蓝盾承诺健康计划在全景城推出一系列以健康为重点的新的、充满活力的社区资源中心

15 小时前

BioLineRx宣布收到纳斯达克最低出价通知

16 小时前

相关公司查看更多

Elekta

治疗设备和软件开发商

立即沟通

产业链接查看更多

所属赛道

治疗设备
近30天,融资2起
肾神经阻断疗法(RDN)介入治疗未控高血压的有效性已基本被证实,RDN有望满足顽固性高血压(RH)及药物不依从的未控高血压患者(UH)的较大需求,一经出世便受到广泛关注。